Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter

被引:14
作者
Berneis, K
Shames, DM
Blanche, PJ
La Belle, M
Rizzo, M
Krauss, RM
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[2] Univ Calif Berkeley, Lawrence Berkeley Lab, Donner Lab, Berkeley, CA 94720 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2004年 / 53卷 / 04期
关键词
D O I
10.1016/j.metabol.2003.10.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To test for intrinsic differences in metabolic properties of low-density lipoprotein (LDL) as a function of particle size, we examined the kinetic behavior of 6 human LDL fractions ranging in size from 251 to 265 A injected intravenously into human apolipoprotein (apo) B transgenic mice. A multicompartmental model was formulated and fitted to the data by standard nonlinear regression using the Simulation, Analysis and Modeling (SAAM 11) program. Smaller sized LDL particles (251 to 257 A) demonstrated a significantly slower fractional catabolic rate (FCR) (0.050 +/- 0.045 h(-1)) compared with particles of larger size (262 to 265 Angstrom) (0.134 +/- -0.015 h(-1), P < .03), and there was a significant correlation between FCR and the peak LDL diameter of the injected fractions (R-2 = .71, P < .034). The sum of the equilibration parameters, k(2,1) and k(1,2), for smaller LDL (0.255 h(-1) and 0.105 h(-1), respectively) was significantly smaller than that for larger LDL (0.277 h(-1) and 0.248 h(-1), respectively; P < .01), indicative of slower intravascular-extravascular exchange for smaller LDL. Therefore in this mouse model, smaller LDL particles are cleared more slowly from plasma than larger LDL and are exchanged more slowly with the extravascular space. This might be due to compositional or structural features of smaller LDL that lead to retarded clearance. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:483 / 487
页数:5
相关论文
共 21 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans [J].
Anber, V ;
Millar, JS ;
McConnell, M ;
Shepherd, J ;
Packard, CJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2507-2514
[3]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[4]   Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[5]   Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system [J].
Bjornheden, T ;
Babyi, A ;
Bondjers, G ;
Wiklund, O .
ATHEROSCLEROSIS, 1996, 123 (1-2) :43-56
[6]  
Blanche Patricia J., 1995, Circulation, V92, pI104
[7]   INTERACTION OF LOW-DENSITY LIPOPROTEINS WITH ARTERIAL PROTEOGLYCANS - THE ROLE OF CHARGE AND SIALIC-ACID CONTENT [J].
CAMEJO, G ;
LOPEZ, A ;
LOPEZ, F ;
QUINONES, J .
ATHEROSCLEROSIS, 1985, 55 (01) :93-105
[8]   Differences in receptor binding of LDL subfractions [J].
Campos, H ;
Arnold, KS ;
Balestra, ME ;
Innerarity, TL ;
Krauss, RM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (06) :794-801
[9]  
COBELLI C, 2000, TRACER KINETICS BIOM, P269
[10]   EVIDENCE FOR KINETIC HETEROGENEITY AMONG HUMAN LOW-DENSITY LIPOPROTEINS [J].
FOSTER, DM ;
CHAIT, A ;
ALBERS, JJ ;
FAILOR, RA ;
HARRIS, C ;
BRUNZELL, JD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (08) :685-696